Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of C5A for the treatment of viral pneumonia

Inhibitors of C5A for the treatment of viral pneumonia

US Patent 10858421 · Granted Dec 8, 2020

Estimated economic value: $3,516,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of pneumonia and ARDS with inhibitors of C5a and IL-6 activity2024
Treatment of pneumonia and ARDS with inhibitors of C5a and IL-6 activity2024
Fused piperidinyl bicyclic and related compounds as modulators of C5a receptor2024
Fused piperidinyl bicyclic and related compounds as modulators of C5a receptor2024
Treatment of inflammatory diseases with inhibitors of C5A activity2024
Treatment of inflammatory diseases with inhibitors of C5A activity2024
Treatment of inflammatory diseases with inhibitors of C5A activity2022
Treatment of inflammatory diseases with inhibitors of C5A activity2022
Treatment of inflammatory diseases with inhibitors of C5a activity2022
Fused piperidinyl bicyclic and related compounds as modulators of C5A receptor2021
Fused piperidinyl bicyclic and related compounds as modulators of C5A receptor2021
Anti-C5a binding moieties with high blocking activity2020